Publications by authors named "Justin Arnall"

27Publications

Ibrutinib treatment via alternative administration in a patient with chronic lymphocytic leukemia and dysphagia.

J Oncol Pharm Pract 2020 Oct 27:1078155220967440. Epub 2020 Oct 27.

Atrium Health, Levine Cancer Institute, Concord, NC, USA.

View Article and Find Full Text PDF
October 2020

Evaluation of Montelukast for the Prevention of Infusion-related Reactions With Daratumumab.

Clin Lymphoma Myeloma Leuk 2020 Oct 7;20(10):e777-e781. Epub 2020 Jun 7.

Department of Hematologic Oncology and Blood Disorders, Atrium Health, Levine Cancer Institute, Charlotte, NC.

View Article and Find Full Text PDF
October 2020

Caplacizumab: an anti-von Willebrand factor antibody for the treatment of thrombotic thrombocytopenic purpura.

Am J Health Syst Pharm 2020 07;77(15):1201-1207

Department of Pharmacy, Levine Cancer Institute, Atrium Health, Concord, NC.

View Article and Find Full Text PDF
July 2020

Necessity of pharmacist-driven nonprescription telehealth consult services in the era of COVID-19.

Am J Health Syst Pharm 2020 07;77(15):1188

Specialty Pharmacy Service at Atrium Health Charlotte, NC.

View Article and Find Full Text PDF
July 2020

Safety and Cost Benefits of the Rapid Daratumumab Infusion Protocol.

Clin Lymphoma Myeloma Leuk 2020 Aug 7;20(8):526-532.e1. Epub 2020 Mar 7.

Plasma Cell Disorders Division, Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute/Atrium Health, Charlotte, NC. Electronic address:

View Article and Find Full Text PDF
August 2020

Vonicog alfa for the management of von Willebrand disease: a comprehensive review and single-center experience.

J Thromb Thrombolysis 2020 Apr;49(3):431-440

Division of Hematology/Oncology, University of Virginia Health System, PO Box 800716, Charlottesville, VA, 22908, USA.

View Article and Find Full Text PDF
April 2020

A successful case of venetoclax-based therapy in relapsed/refractory secondary plasma cell leukemia.

J Oncol Pharm Pract 2020 Jul 22;26(5):1274-1278. Epub 2019 Dec 22.

Plasma Cell Disorders, Levine Cancer Institute, Charlotte, NC, USA.

View Article and Find Full Text PDF
July 2020

A Review of Growth Factor Support in Bloodless Autologous Hematopoietic Stem Cell Transplant.

Biol Blood Marrow Transplant 2019 10 8;25(10):e305-e309. Epub 2019 Jul 8.

Pennsylvania Hospital, Center for Bloodless Medicine and Surgery, Philadelphia, , Pennsylvania.

View Article and Find Full Text PDF
October 2019

Enhancing the feasibility of outpatient daratumumab administration via a split-dosing strategy with initial doses.

Leuk Lymphoma 2019 09 8;60(9):2295-2298. Epub 2019 Mar 8.

Department of Hematologic Oncology and Blood Disorders, Atrium Health, Levine Cancer Institute , Charlotte , NC , USA.

View Article and Find Full Text PDF
September 2019

Ibrutinib for the treatment of Bing-Neel syndrome, a complication of Waldenström macroglobulinemia: Patient case report.

J Oncol Pharm Pract 2019 Sep 13;25(6):1534-1539. Epub 2019 Feb 13.

2 Department of Oncology, Carolinas Healthcare System NorthEast, Levine Cancer Institute, Concord, NC, USA.

View Article and Find Full Text PDF
September 2019

Daratumumab, pomalidomide, and dexamethasone as a bridging therapy to autologous stem cell transplantation in a case of systemic light-chain amyloidosis with advanced cardiac involvement.

J Oncol Pharm Pract 2019 Jun 26;25(4):1021-1025. Epub 2018 Nov 26.

2 Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.

View Article and Find Full Text PDF
June 2019

Transitioning historically inpatient chemotherapy regimens for hematologic malignancies to the ambulatory care setting.

Am J Health Syst Pharm 2018 Nov 21;75(22):1824-1830. Epub 2018 Aug 21.

Department of Pharmacy, Levine Cancer Institute, Atrium Health, Charlotte, NC.

View Article and Find Full Text PDF
November 2018